dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

Louisiana getting $14 million Center for Molecular Imaging and Therapy Increasing research opportunities, collaboration and radiopharmaceuticals

PET uncovers abnormal tau deposits associated with CTE in live subjects May enable diagnosis of CTE in living people one day

DOE transfers land to Coquí Pharma for isotope production facility Will be used primarily to produce Mo-99

Amyloid PET scans help with Alzheimer's clinical management New insights from the 11,000 patient IDEAS study

United Imaging's total-body PET scanner shows promise in four new studies Faster scans, lower dose and 'a level of detail never seen in PET'

NorthStar buys IBA electron accelerators for Mo-99 production Will increase production capacity and efficiencies

RadioMedix and Vect-Horus to develop brain theranostic agent for brain cancer Provide diagnosis and treatment of Glioblastoma Multiforme (GBM)

NIH awards $1.8 million to Magnetic Insight for neurovascular MPI Detects magnetic nanoparticle tracers, enables deep-tissue imaging

DOE to cut Moly-99 deals with four US firms Could be as much as $15 million per company, with partners matching awarded amounts

Women's brains appear three years younger than men's at the same age: PET study A machine-learning algorithm assisted with the analysis

Former executives of Necsa are
attempting to overturn their
suspensions in court

Former South African nuclear executives to appeal suspensions in court

by John R. Fischer , Staff Reporter
Former board members of the South African Nuclear Energy Company (Necsa) have resorted to paying 1.5 million rands (more than $108,000) in out-of-pocket expenses to hold a court hearing this week in an attempt to overturn their suspensions, according to Moneyweb.

Energy minister Jeff Radebe dismissed chairman Kelvin Kemm, CEO Phumzile Tshelane and audit and risk director Pamela Bosman this past November, accusing them of exhibiting “defiance and ineptitude” through their actions. In response, the three claim their dismissal is related to the minister’s involvement in a plan to sell NTP Radioisotopes, a Necsa subsidiary and medical isotope production plant, to an American buyer.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



The allegations made against the trio include unauthorized foreign trips, the relaying of false information to the press, and the approval of unauthorized increases in remuneration. Radebe says recommendations were made by the Department of Energy to replace the three ahead of 2019 when their positions would be up for renewal, and argues that reinstating them would disrupt the workflow of the nuclear company under its new board.

One of the primary reasons provided to justify the suspensions centers around the monthslong shutdown of the NTP facility, one of the few profitable state-owned companies, which suspended operations in November 2017 due to a suspected hydrogen leak. The facility started up production once more in February 2018, upon receiving approval from the NNR.

“We remain eternally grateful to our customers in the United States, Europe, Japan, Middle East and South Africa who showed their unwavering support and wished us well,” said Tshelane at the time of its reopening. “To all our stakeholders globally, who were affected, we thank you for your understanding and patience. Your empathy throughout this period is highly appreciated.”

Operations, however, ceased once more at the end of May, when it was discovered that operators were not ensuring the facility was in safe mode before starting production runs. The employees found responsible were subsequently removed from the plant, with three re-engaged after accepting blame and one opting for early retirement. Production recommenced at NTP in November.

Radebe attributes the cause to an apparent lack of leadership by Necsa, though Kemm argues in his affidavit that Necsa retains its own legal personality, board and balance sheet, as evidenced by the fact that that the regulator instructed NTP directly to shut down Cell 19 of its reactor, rather than Necsa.
  Pages: 1 - 2 - 3 >>

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED